Recent trends in mortality due to chronic obstructive pulmonary disease (COPD) in Mexico, 1980-2002

被引:6
|
作者
Guzmán, VJT [1 ]
Antuñano, FJL [1 ]
Salgado, NR [1 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest & Salud Poblac, Dept Invest & Tabaco, Cuernavaca 62508, Morelos, Mexico
关键词
mortality; COPD; Mexico; epidemiology; trends;
D O I
10.1016/j.arcmed.2004.11.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible. Changes in classification have a major impact on reported mortality rates. Methods. Between 1980 and 2002, 230,463 COPD cases were studied (age group 35-94 years); 134,579 men; 95,884 women. Results. The crude mortality rate varied from 37 (1980) to 61 per 100,000 men (2002), (increase: 65%). The crude mortality rate for females increased from 27 (1980) to 43 deaths per 100,000 women (2002), (increase: 56%). The trends of the absolute values by birth year and age groups are higher as age increases. As age of death comes down and the birth cohort increases, the absolute values decrease. The Mexican states located in the northern and central areas present a higher risk for dying. There is an increment coefficient of 93 cases per increment year in males (age group 35-74), and 61 cases per increment year in females (age group 35-74 years). For the age group 35-94 years, the annual increase for males is 288 cases. These results were statistically significant, and the regression model was validated by residual analysis. Conclusions. The oldest cohorts of the studied population showed the highest COPD mortality absolute values. The geographic risk of dying from COPD is concentrated in two regions: a) the three Mexican states of higher economic income at the northern frontier to the U.S. and b) those Mexican states surrounding the main producer of tobacco (Nayarit). (c) 2005 IMSS. Published by Elsevier Inc.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
  • [21] Chronic obstructive pulmonary disease (COPD)
    Pahl, Andreas
    Szelenyi, Istvan
    DRUGS OF THE FUTURE, 2007, 32 (09) : 799 - 807
  • [22] Chronic Obstructive Pulmonary Disease (COPD)
    Weitzenblum, E.
    EUROPEAN RESPIRATORY REVIEW, 2009, 18 (112): : 133 - 133
  • [23] Chronic obstructive pulmonary disease (COPD)
    Senior, RM
    Anthonisen, NR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) : S139 - S147
  • [24] Chronic Obstructive Pulmonary Disease (COPD)
    S. Desole
    C. M. Kähler
    memo - Magazine of European Medical Oncology, 2008, 1 (Suppl 3) : 3 - 6
  • [25] Chronic obstructive pulmonary disease (COPD)
    Pommer, Peter
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (49) : 2589 - 2589
  • [26] Chronic obstructive Pulmonary Disease (COPD)
    Koczulla, A. -R.
    Greulich, T.
    Beutel, B.
    Vogelmeier, C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (22) : 1185 - 1187
  • [27] Chronic obstructive pulmonary disease in 2002
    Jiménez, AL
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (08): : 377 - 377
  • [28] Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?
    Mcvay, Gillian
    Meharry, Rosie
    Young, David
    Sinton, Leigh
    Hannah, Deborah
    MacKay, Elaine
    Anderson, David
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)
    Lokesh
    Gulati, Nisha
    Saini, Annu
    Singh, Sachin Kumar
    Gupta, Gaurav
    MacLoughlin, Ronan
    Chellappan, Dinesh Kumar
    Dua, Kamal
    Dureja, Harish
    CURRENT DRUG DELIVERY, 2024,
  • [30] The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991
    Jacobson, L
    Hertzman, P
    Löfdahl, CG
    Skoogh, BE
    Lindgren, B
    RESPIRATORY MEDICINE, 2000, 94 (03) : 247 - 255